• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童用 COVID-19 疫苗。

COVID-19 vaccines for children.

机构信息

Jeffrey S. Gerber is an associate professor of Pediatrics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA and deputy director of the Center for Pediatric Clinical Effectiveness at Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Paul A. Offit is the director of the Vaccine Education Center in the Division of Infectious Diseases at Children's Hospital of Philadelphia, Philadelphia, PA, USA and a professor in the Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

出版信息

Science. 2021 Nov 19;374(6570):913. doi: 10.1126/science.abn2566. Epub 2021 Nov 18.

DOI:10.1126/science.abn2566
PMID:34793207
Abstract

Earlier this month, the US Centers for Disease Control and Prevention (CDC) recommended Pfizer's COVID-19 messenger RNA (mRNA) vaccine for children between 5 and 11 years of age-that's 28 million children. Yet surveys show that 42 to 66% of parents of these children are reluctant or opposed to seeking this protection. Without vaccination, it is likely that almost everyone-including young children-will be infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at some point in their lives. So, the question for parents and caregivers is: Which is worse, vaccination or natural infection?

摘要

本月早些时候,美国疾病控制与预防中心(CDC)建议为 5 至 11 岁儿童接种辉瑞的 COVID-19 信使 RNA(mRNA)疫苗——这涉及 2800 万名儿童。然而,调查显示,这些儿童的家长中有 42%至 66%不愿意或反对寻求这种保护。如果不接种疫苗,几乎每个人——包括幼儿——在其一生中的某个时刻都有可能感染严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)。因此,对于父母和照顾者来说,问题是:接种疫苗和自然感染,哪个更糟糕?

相似文献

1
COVID-19 vaccines for children.儿童用 COVID-19 疫苗。
Science. 2021 Nov 19;374(6570):913. doi: 10.1126/science.abn2566. Epub 2021 Nov 18.
2
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.mRNA COVID-19 疫苗接种后出现心肌炎报告:免疫实践咨询委员会更新-美国,2021 年 6 月。
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.
3
Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.2019冠状病毒病mRNA疫苗接种后确诊的急性心肌炎
Circ J. 2022 Mar 25;86(4):724. doi: 10.1253/circj.CJ-21-0840. Epub 2021 Dec 4.
4
Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age.12至18岁青少年接种2019冠状病毒病信使核糖核酸疫苗后的心肌心包炎
J Pediatr. 2021 Nov;238:26-32.e1. doi: 10.1016/j.jpeds.2021.07.044. Epub 2021 Jul 30.
5
Evaluation of COVID-19 Vaccine Refusal in Parents.评估父母对新冠疫苗的拒绝情况。
Pediatr Infect Dis J. 2021 Apr 1;40(4):e134-e136. doi: 10.1097/INF.0000000000003042.
6
The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021.免疫实践咨询委员会关于 COVID-19 疫苗加强针和额外基础针的临时建议-美国,2021 年。
MMWR Morb Mortal Wkly Rep. 2021 Nov 5;70(44):1545-1552. doi: 10.15585/mmwr.mm7044e2.
7
Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccines.美国疾病控制与预防中心监测系统在评估新冠疫苗授权后安全性方面取得的成效。
Expert Rev Vaccines. 2022 Mar;21(3):281-284. doi: 10.1080/14760584.2022.2019020. Epub 2022 Jan 5.
8
Myocarditis after vaccination against covid-19.接种新冠疫苗后发生的心肌炎
BMJ. 2021 Dec 16;375:n3090. doi: 10.1136/bmj.n3090.
9
[Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology].[新型冠状病毒肺炎mRNA疫苗接种后的心肌炎和心包炎。意大利心脏病学会专家意见]
G Ital Cardiol (Rome). 2021 Nov;22(11):894-899. doi: 10.1714/3689.36747.
10
Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.COVID-19 疫苗追加剂量的安全性监测 - 美国,2021 年 8 月 12 日至 9 月 19 日。
MMWR Morb Mortal Wkly Rep. 2021 Oct 1;70(39):1379-1384. doi: 10.15585/mmwr.mm7039e4.

引用本文的文献

1
COVID-19 clinical presentation, management, and epidemiology: a concise compendium.新型冠状病毒肺炎的临床表现、治疗与流行病学:简明概要
Front Public Health. 2025 Jan 31;13:1498445. doi: 10.3389/fpubh.2025.1498445. eCollection 2025.
2
COVID-19 vaccine updates for people under different conditions.不同人群的 COVID-19 疫苗更新信息。
Sci China Life Sci. 2024 Nov;67(11):2323-2343. doi: 10.1007/s11427-024-2643-1. Epub 2024 Jul 29.
3
Effects of COVID-19 vaccine safety framing on parental reactions.新冠疫苗安全表述对家长反应的影响。
PLoS One. 2024 Apr 16;19(4):e0302233. doi: 10.1371/journal.pone.0302233. eCollection 2024.
4
The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8.E3 连接酶 TRIM22 通过促进 NSP8 的蛋白酶体降解来限制 SARS-CoV-2 的复制。
mBio. 2024 Feb 14;15(2):e0232023. doi: 10.1128/mbio.02320-23. Epub 2024 Jan 26.
5
COVID-19 Vaccine Uptake in Immigrant, Refugee, and Nonimmigrant Children and Adolescents in Ontario, Canada.加拿大安大略省移民、难民和非移民儿童和青少年的 COVID-19 疫苗接种情况。
JAMA Netw Open. 2023 Jul 3;6(7):e2325636. doi: 10.1001/jamanetworkopen.2023.25636.
6
Medical outcomes of children with neurodevelopmental disorders after SARS-CoV-2 vaccination: A six-month follow-up study.SARS-CoV-2 疫苗接种后神经发育障碍儿童的医疗结局:一项为期六个月的随访研究。
Vaccine. 2023 Jun 29;41(29):4267-4273. doi: 10.1016/j.vaccine.2023.05.067. Epub 2023 May 29.
7
BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer-A 1-Year Follow-Up.BNT162b2新冠疫苗在患有癌症的儿童、青少年和年轻人中的应用——1年随访
Vaccines (Basel). 2023 May 16;11(5):989. doi: 10.3390/vaccines11050989.
8
Willingness to vaccinate children against COVID-19 declined during the pandemic.在大流行期间,儿童接种 COVID-19 疫苗的意愿下降。
Vaccine. 2023 Apr 6;41(15):2495-2502. doi: 10.1016/j.vaccine.2023.02.069. Epub 2023 Mar 2.
9
Mothers' Intention to Vaccinate Their Children Aged 5-11 Against COVID-19: A Cross-sectional Survey.母亲为5至11岁儿童接种新冠疫苗的意愿:一项横断面调查
Oman Med J. 2023 Jan 31;38(1):e462. doi: 10.5001/omj.2023.47. eCollection 2023 Jan.
10
Reported rates of all-cause serious adverse events following immunization with BNT-162b in 5-17-year-old children in the United States.美国 5-17 岁儿童接种 BNT-162b 后全因严重不良事件的报告率。
PLoS One. 2023 Feb 17;18(2):e0281993. doi: 10.1371/journal.pone.0281993. eCollection 2023.